What Can Cause a Positive ANA Test?

A positive antinuclear antibody (ANA) test can be caused by dozens of things, and most of them are not lupus. Autoimmune diseases are the most clinically significant cause, but infections, certain medications, normal aging, and even just being female all raise the odds of a positive result. In one study of apparently healthy people, roughly one in three tested positive at a low dilution level, and about one in twenty tested positive at levels usually considered meaningful.¹ Understanding why the test turns positive so often without disease is the first step toward making sense of your own result.

Healthy People Test Positive Surprisingly Often

The single most common reason for a positive ANA test is having no disease at all. ANA positivity in the general healthy population ranges from about 5 to 13 percent depending on the cutoff used, and the rate climbs higher at lower dilution thresholds. A large Chinese health-screening study found a positive rate of roughly 7 percent overall, with women positive about twice as often as men.² Data from the Baltimore Longitudinal Study of Aging found that about 15 percent of women and 9 percent of men were ANA-positive, with sex differences most pronounced in younger adults and converging after age 80.³

Age is an independent driver. ANA positivity shows a significant upward trend across age groups, and a majority of ANA-positive individuals in large population studies are over 50.⁴ A large tertiary-care cohort confirmed that ANA positivity rates increase significantly across age groups and are consistently higher in women.⁵ The bottom line for healthy people: a low-titer positive ANA in an older woman who feels perfectly fine is one of the most common lab results a doctor will see, and by itself it usually means nothing.

Systemic Autoimmune Diseases

This is the association most people worry about. Systemic lupus erythematosus is the disease most strongly linked to ANA, and the test is sensitive enough that a negative ANA essentially rules lupus out. A meta-regression of the literature confirmed that ANA tested by immunofluorescence at a titer of 1:80 has sufficiently high sensitivity to serve as an entry criterion for lupus classification.⁶ When compared against healthy controls, ANA at a titer of 1:80 or above had a sensitivity of 98 percent for lupus.⁷ But sensitivity is not the same as specificity. Higher titers and the presence of multiple autoantibody types dramatically improve the odds that a positive ANA actually points to lupus.⁸

ANA is also positive in most people with systemic sclerosis (scleroderma), though the specific proteins targeted by the antibodies differ from those in lupus.⁹ Sjögren’s syndrome and polymyositis/dermatomyositis are other connective tissue diseases where ANA commonly shows up. Mixed connective tissue disease (MCTD) is defined in part by the presence of anti-U1RNP antibodies, which themselves produce a positive ANA with a characteristic coarse speckled pattern.¹⁰ The common thread across these conditions is that the immune system produces antibodies directed against components of the cell nucleus, but the specific nuclear target varies from disease to disease, which is why follow-up testing matters so much.

Organ-Specific Autoimmune Conditions

Autoimmune diseases that target a single organ can also trigger a positive ANA, even though ANA is more classically associated with systemic conditions. Autoimmune hepatitis (AIH) is one of the best-known examples. Patients with AIH frequently have a homogeneous ANA pattern, and this pattern becomes even more common when autoimmune thyroid disease is present alongside AIH.¹¹

Autoimmune thyroid disease on its own can push ANA positive. A study of a general screening population found that the risk of ANA positivity climbed steadily with rising levels of thyroid peroxidase and thyroglobulin antibodies. People with the highest thyroid antibody levels were roughly two to three times more likely to test ANA-positive than those with normal thyroid markers.¹² This means that someone with Hashimoto’s thyroiditis or Graves’ disease who tests ANA-positive does not necessarily have a second autoimmune disease. The thyroid condition alone may be responsible.

Medications That Can Trigger ANA

Drug-induced ANA is one of the more confusing causes because the list of implicated medications is long, but the evidence that any single drug reliably causes ANA at a population level is surprisingly thin. A U.S. population-level study using national health survey data found no strong evidence that most medications traditionally blamed for ANA positivity were actually risk factors in the general population, though the researchers acknowledged limited statistical power for some drugs.¹³ The classic offenders taught in medical school, drugs like hydralazine, procainamide, and isoniazid, can clearly induce ANA and sometimes a lupus-like syndrome in individual patients, but the overall population risk seems lower than textbooks imply.

Biologic therapies are a different story. About a fifth of patients treated with TNF-alpha inhibitors, widely used for rheumatoid arthritis and inflammatory bowel disease, developed a new positive ANA during treatment.¹⁴ Newer immune checkpoint inhibitors used in cancer treatment have also been linked to developing autoantibodies, including ANA, sometimes before joint inflammation or other autoimmune side effects appear.¹⁵ If you are on one of these medications and a positive ANA shows up, your doctor will weigh whether the drug is the likely culprit before pursuing an autoimmune workup.

Infections

Acute and chronic infections can stimulate ANA production. The immune system’s intense activity during an infection sometimes generates antibodies that cross-react with nuclear material. Epstein-Barr virus (EBV, the cause of mononucleosis) is one of the best-studied infectious triggers. Patients with past EBV infection and those experiencing viral reactivation had significantly higher rates of ANA positivity than uninfected individuals, with reactivation carrying the highest rates.¹⁶ Other infections associated with ANA positivity include hepatitis C, tuberculosis, subacute bacterial endocarditis, and HIV.¹⁷

The ANA triggered by infection is usually transient. Once the infection resolves or is controlled, the antibodies tend to fade. This is another reason doctors avoid reading too much into a single positive ANA drawn during or shortly after an illness.

Cancer and Paraneoplastic Responses

Certain cancers can provoke an immune response that includes ANA production, a phenomenon sometimes called a paraneoplastic autoimmune response. The body recognizes tumor-associated proteins as foreign, and in the process, generates antibodies that happen to bind nuclear antigens. A study of ANA patterns and cancer found that a nucleolar ANA pattern, specifically, carried an increased relative risk of about 1.5 for having an associated cancer. The antibodies anti-Scl70 and anti-RNA polymerase III were each associated with cancer in roughly 14 to 15 percent of cases.¹⁸

A case report of paraneoplastic cerebellar degeneration illustrated the diagnostic confusion this can create: positive ANA findings led clinicians down an autoimmune workup when the actual underlying cause was a malignancy.¹⁹ This is uncommon, but it is worth knowing that a positive ANA does not always mean autoimmunity. In patients with unexplained neurological symptoms or other red flags, cancer-specific antibody testing may be warranted alongside the standard autoimmune workup.

Environmental Exposures and Vaccines

Occupational and environmental exposures can prime the immune system toward autoantibody production. Inhaling crystalline silica dust, an exposure common in mining, construction, and sandblasting, has been strongly linked to the development of autoimmune connective tissue diseases including lupus and rheumatoid arthritis.²⁰ People with heavy silica exposure who turn up ANA-positive deserve closer monitoring than the general population, because their risk of progressing to clinical autoimmune disease is higher.

Vaccines occasionally produce transient autoantibody responses. A study following 92 healthy adults after annual influenza vaccination found that a small number developed a temporary increase in autoantibodies.²¹ Similar findings appeared after mRNA COVID-19 vaccination: about 5 percent of previously ANA-negative participants briefly turned positive, but the antibodies were gone by three months.²² These findings are important context if you happen to have an ANA test drawn shortly after vaccination, but they do not indicate lasting immune disruption.

Why Titer and Pattern Matter More Than a Simple Positive

Not all positive ANAs are created equal. The titer (essentially a measure of how concentrated the antibodies are) and the staining pattern (how the antibodies bind to cells under a microscope) carry very different clinical meanings.

At a low titer like 1:40, roughly a third of healthy people will test positive. At 1:160, about 5 percent will. At 1:320, about 3 percent still do.¹ Most labs now use 1:80 or 1:160 as the reporting threshold, which helps filter out some of the background noise. But even at these cutoffs, plenty of healthy people will be flagged.

Pattern adds another layer of information. A study comparing ANA-positive healthy people with patients who had autoimmune rheumatic diseases found strikingly different pattern profiles. Homogeneous, coarse speckled, and centromeric patterns appeared exclusively in the disease group. A specific pattern called dense fine speckled (DFS) appeared only in healthy individuals.²³ An international consensus panel confirmed that the DFS pattern is clinically relevant specifically because it suggests that lupus, Sjögren’s, and scleroderma are unlikely.²⁴ So if your ANA report mentions a dense fine speckled pattern, that is actually reassuring rather than alarming.

Testing method also influences results. The traditional approach uses immunofluorescence on a cell line called HEp-2, where a technician looks through a microscope for glowing patterns. Newer ELISA-based tests use automated plates. In at least one head-to-head comparison, ELISA showed slightly better sensitivity and specificity than immunofluorescence for connective tissue disease screening.²⁵ Another comparison found that immunofluorescence had lower specificity than ELISA, meaning it was more likely to produce false positives.²⁶ Depending on which method your lab used, the false-positive rate changes. This is not something patients typically control, but it helps explain why a positive ANA at one lab can turn negative at another.

Pre-Clinical Autoimmunity

Here is where things get genuinely interesting and a little unsettling. Some people who are ANA-positive today and feel perfectly healthy will go on to develop a clinical autoimmune disease years later. A landmark study using stored military serum samples found that 88 percent of people eventually diagnosed with lupus had at least one lupus-related autoantibody present before their diagnosis, sometimes nearly a decade beforehand. ANA was present an average of about 3.4 years before clinical lupus appeared.²⁷

This does not mean every healthy ANA-positive person is on a path toward disease. Most are not. But it does mean that a positive ANA in someone with vague symptoms that do not yet meet diagnostic criteria deserves follow-up rather than dismissal. The concept of pre-clinical autoimmunity, a detectable immune signature that precedes symptoms, is one reason rheumatologists take higher-titer ANA results seriously even when the patient looks well at that moment.

ANA and Recurrent Pregnancy Loss

ANA testing comes up frequently in fertility workups, particularly for women with recurrent miscarriages. A meta-analysis pooling over 5,000 participants found that women with recurrent pregnancy loss had a significantly higher ANA-positive rate (about 22 percent) compared to controls (about 8 percent). The association was strongest at higher titers: ANA at 1:160 or above was dramatically more common in affected women, while low titers in the 1:40 to 1:80 range did not significantly predict pregnancy loss.²⁸

An Iranian study of women with unexplained recurrent miscarriage found ANA in about 13 percent of cases versus under 1 percent of healthy controls.²⁹ One hypothesis is that ANA positivity in these women signals an underlying autoimmune process that interferes with early placental development, even if the woman has no diagnosable autoimmune disease.³⁰ If you have experienced multiple miscarriages and your ANA comes back positive at a meaningful titer, it is worth discussing with both a rheumatologist and a reproductive specialist.

ANA Testing in Children

Pediatricians order ANA tests frequently, and the results cause a lot of parental anxiety. The test is overused in children, where its specificity and sensitivity for most rheumatic conditions are low. A widely cited review argued that ANA should not be ordered as a screening test for children with nonspecific complaints like joint pain or fatigue. It should only be used when a child already has definite signs and symptoms suggesting lupus or mixed connective tissue disease.³¹

A positive ANA in a child who otherwise looks healthy and has no clinical findings of autoimmune disease is very likely to be meaningless. The positive predictive value of ANA for connective tissue disease drops sharply when the likelihood of disease was low in the first place.³² A low titer (below 1:640) in a well child can generally be ignored. By limiting unnecessary ANA testing, pediatricians can spare families the cascade of specialist referrals, additional blood draws, and worry that inevitably follows a positive result in a child who was fine all along.

What Happens After a Positive ANA

A positive ANA is a starting point, not a diagnosis. The standard next step is to test for extractable nuclear antigens (ENAs), a panel of specific antibodies like anti-Smith, anti-Ro, anti-La, anti-Scl-70, and anti-U1RNP, each of which points toward a particular condition. Whether your doctor orders this panel depends on the ANA titer and pattern.³³

Higher titers predict ENA positivity more reliably. In one hospital cohort, moderate and higher titers (1:320 and above) showed a strong association with positive ENA results, while certain patterns like speckled and homogeneous were more predictive than others. Interestingly, about 9 percent of patients who tested ANA-negative still turned out to be ENA-positive, a reminder that no single test is perfect and clinical judgment remains essential.³⁴ Your doctor will integrate your ANA result with your symptoms, physical exam, and other lab work to decide whether a positive result warrants further investigation or simple reassurance.

When a Positive ANA Means Something and When It Does Not

A few rules of thumb help sort signal from noise. A high titer (1:320 or above) with a homogeneous or speckled pattern in someone with joint pain, rashes, or unexplained fatigue deserves a thorough workup. A low titer with a dense fine speckled pattern in someone who feels well is almost always a benign finding. Context drives everything: the same result means different things in a 25-year-old with mouth sores and hair loss versus a 70-year-old with no symptoms who happened to get the test on a routine panel.

The biggest misconception about ANA testing is that a positive result equals disease. It does not. ANA is a screening test with deliberately high sensitivity, meaning it is designed to catch as many true cases of autoimmune disease as possible, at the cost of flagging many healthy people along the way. Roughly 90 percent or more of people with a positive ANA at low titers do not have and will not develop a systemic autoimmune condition. If your doctor tells you a mildly positive ANA is nothing to worry about, there is good reason to believe them.